Author

Thomas Kay

University of Rochester

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Aurélie BertiniD· 1 shared Cameron W. A. SnyderiD· 1 shared Chandhana Ravi· 1 shared Dan T. BergstralhiD· 1 shared Elizabeth A. LaMere· 1 shared Elizabeth Pritchette· 1 shared Erdem D. TabdanoviD· 1 shared Gwenyth C. EichfeldiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aurélie BertinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reconstruction of septin higher-order nano-size structures in ovarian cancer cells uncover susceptibility to the septin-targeting small molecule UR214-9

Negar Khazan, Cameron W. A. Snyder, Nicole Dawney, Elizabeth A. LaMere, Srinivasan Ekambaram, Niloy A. Singh, Chandhana Ravi, Rajiv Snape, Hannah E. Aichelman, Elizabeth Pritchette, John M. Ashton, Thomas Kay, Myla S. Strawderman, Naohiro Yano, Dan T. Bergstralh, , Rakesh K. Singh

This paper demonstrates that UR214-9 disrupts septin hetero-octamerization, leading to aberrant structures and impairing cancer cell functions.

bioRxiv · Jun 9, 2026 · PreprintCancer Biology